Cargando…

Efficacy and Safety of Cyclophosphamide Low-Dose Pre-Phase Chemotherapy in Diffuse Large B Cell Lymphoma with Gastrointestinal Involvement

BACKGROUND: Gastric Diffuse large B-cell lymphoma (DLBCL) is the most common extranodal site of lymphoma’s involvement (30%–40% of all extranodal lymphomas and 55%–65% of all gastrointestinal lymphomas). However, gastric localizations are also sometimes found in systemic DLBCL. Gastric complications...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guarnera, Luca, Meconi, Federico, Secchi, Roberto, Pascale, Maria Rosaria, Esposito, Fabiana, Zizzari, Annagiulia, Rapisarda, Vito Mario, Rizzo, Manuela, Pupo, Livio, Cantonetti, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992639/ https://www.ncbi.nlm.nih.gov/pubmed/35444769 http://dx.doi.org/10.4084/mjhid.2022.017

Ejemplares similares

Aggressive Primary Cutaneous Anaplastic T-Cell Lymphoma Successfully Treated with Autologous Stem Cell Transplant and Brentuximab Vedotin Consolidation: Case Report and Review of the Literature
por: Guarnera, Luca, et al.
Publicado: (2022)

Primary Cutaneous Anaplastic Large Cell Lymphoma of the Oral Cavity Successfully Treated with Brentuximab Vedotin
por: Meconi, Federico, et al.
Publicado: (2019)

The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma
por: Palmieri, R., et al.
Publicado: (2019)

A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
por: Meconi, Federico, et al.
Publicado: (2020)

Body Composition in Patients with Follicular Lymphoma: Asso-Ciations between Changes in Radiomic Parameters in Patients Treated with R-CHOP-like and R-B Regimens: LyRa 01F
por: Esposito, Fabiana, et al.
Publicado: (2023)

Recurrent Sweet's syndrome in a patient with multiple myeloma
por: Gurnari, Carmelo, et al.
Publicado: (2018)

Role of Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Mycosis Fungoides
por: Di Raimondo, Cosimo, et al.
Publicado: (2023)

Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir
por: Campogiani, Laura, et al.
Publicado: (2019)

Coexistence of T-Large Granular Lymphocyte Leukemia and Peripheral T Cell Lymphoma-NOS with Indolent Behavior
por: Guarnera, Luca, et al.
Publicado: (2022)

Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high ‘life threat’ impact cardiopathy
por: Corazzelli, Gaetano, et al.
Publicado: (2011)

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
por: Candelaria, Myrna, et al.
Publicado: (2021)

Primary Gastrointestinal Diffuse Large B-cell Lymphoma
por: Lodhi, Hanan T, et al.
Publicado: (2018)

Influence of Severe Gastrointestinal Complications in Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Shen, Ye, et al.
Publicado: (2021)

Computed tomography findings of diffuse gastrointestinal mantle cell lymphoma
por: Yamauchi, Fernando Ide, et al.
Publicado: (2017)

Diffuse Large B Cell Lymphoma with Cutaneous and Gastrointestinal Involvement
por: Kyaw, Aye-Mya-Mya, et al.
Publicado: (2022)

Gastrointestinal tract metastasis of mandibular diffuse large B‐cell lymphoma
por: Yucesoy, Turker, et al.
Publicado: (2018)

A Prognostic Model of Gastrointestinal Diffuse Large B Cell Lymphoma
por: Gao, Fan, et al.
Publicado: (2021)

Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
por: Go, Se‐Il, et al.
Publicado: (2016)

Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Gupta, Varsha, et al.
Publicado: (2022)

Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
por: Horvat, Matej, et al.
Publicado: (2018)

Clinicopathological analysis of primary refractory diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy
por: Suzuki, Tomotaka, et al.
Publicado: (2021)

Prognostic value of immunohistochemical algorithms in gastrointestinal diffuse large B-cell lymphoma
por: Hwang, Hee Sang, et al.
Publicado: (2013)

Massive Upper Gastrointestinal Bleeding Caused by Diffuse Large B-Cell Lymphoma
por: Telci Caklili, O., et al.
Publicado: (2016)

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Li, Peifeng, et al.
Publicado: (2021)

Primary Gastrointestinal Diffuse Large B-cell Lymphoma Presenting as Ileal Perforation
por: Rumney, Sean, et al.
Publicado: (2023)

Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma
por: Veal, Gareth J., et al.
Publicado: (2016)

Treatment associated Mantle Cell Lymphoma with Cyclophosphamide therapy for Granulomatosis with Polyangiitis
por: Sheehy, Robert, et al.
Publicado: (2015)

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth
por: Lee, Eun Ju, et al.
Publicado: (2014)

Diagnostic Performance and Safety of Bronchoalveolar Lavage in Thrombocytopenic Haematological Patients for Invasive Fungal Infections Diagnosis: A Monocentric, Retrospective Experience
por: Cefalo, Mariagiovanna, et al.
Publicado: (2019)

Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide
por: Malvicini, Mariana, et al.
Publicado: (2012)

Primary Gastrointestinal Diffuse Large B Cell Lymphoma Presenting with Cold Agglutinin Disease
por: Eskazan, Ahmet Emre, et al.
Publicado: (2011)

Diffuse Juvenile Bullous Pemphigoid Managed Successfully With a Short Course of Cyclophosphamide
por: Rani, Seema, et al.
Publicado: (2022)

Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
por: Niscola, Pasquale, et al.
Publicado: (2013)

Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma
por: Hornberger, John, et al.
Publicado: (2008)

Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide
por: Ohe, Masashi, et al.
Publicado: (2013)

Immunophenotype classification and therapeutic outcomes of Chinese primary gastrointestinal diffuse large B-cell lymphoma
por: Zhang, Zizhen, et al.
Publicado: (2012)

Severe cyclophosphamide-related hyponatremia in a patient with acute glomerulonephritis
por: Esposito, Pasquale, et al.
Publicado: (2017)

Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
por: Song, Guoqi, et al.
Publicado: (2016)

Primary gastrointestinal lymphoma
por: Aledavood, Amir, et al.
Publicado: (2012)

Stimulation of granulocytic colony formation in agar diffusion chambers implanted in cyclophosphamide pretreated mice.
por: Gordon, M. Y., et al.
Publicado: (1975)

Cannot write session to /tmp/vufind_sessions/sess_pun9cdjrb9vl6s6a79tf7nroa4